Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Angion Biomedica (ANGN)
NASDAQ:ANGN
Angion Biomedica (ANGN) Stock Price & Analysis
154 Followers
ANGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.46 - $2.04
Previous Close$0.95
Volume722.19K
Average Volume (3M)70.51K
Market Cap
$28.60M
Enterprise Value-$301.00K
Total Cash (Recent Filing)$29.20M
Total Debt (Recent Filing)$297.00K
Price to Earnings (P/E)-1.0
Beta2.18
Next Earnings
Aug 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding30,113,703
10 Day Avg. Volume162,209
30 Day Avg. Volume70,506
Standard Deviation0.21
R-Squared0.02
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)0.62
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.46
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Angion Biomedica News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANGN FAQ
What was Angion Biomedica’s price range in the past 12 months?
Angion Biomedica lowest stock price was $0.46 and its highest was $2.04 in the past 12 months.
What is Angion Biomedica’s market cap?
Currently, no data Available
When is Angion Biomedica’s upcoming earnings report date?
Angion Biomedica’s upcoming earnings report date is Aug 10, 2023 which is in 74 days.
How were Angion Biomedica’s earnings last quarter?
Angion Biomedica released its earnings results on May 15, 2023. The company reported -$0.151 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.151.
Is Angion Biomedica overvalued?
According to Wall Street analysts Angion Biomedica’s price is currently Overvalued.
Does Angion Biomedica pay dividends?
Angion Biomedica does not currently pay dividends.
What is Angion Biomedica’s EPS estimate?
Angion Biomedica’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Angion Biomedica have?
Angion Biomedica has 30,113,703 shares outstanding.
What happened to Angion Biomedica’s price movement after its last earnings report?
Angion Biomedica reported an EPS of -$0.151 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.282%.
Which hedge fund is a major shareholder of Angion Biomedica?
Currently, no hedge funds are holding shares in ANGN
---
Angion Biomedica Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.10%
12-Months-Change
Fundamentals
Return on Equity
-54.47%
Trailing 12-Months
Asset Growth
-48.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Angion Biomedica
Angion Biomedica Corp was incorporated in the State of Delaware on April 6. 1998. It is a clinical stage biopharmaceutical company. The Company discovers and develops novel therapeutic agents to treat acute and chronic organ injury by harnessing the body's protective, reparative and regenerative systems. It is developing therapeutics for both orphan indications and large clinical markets of unmet medical need.
---
Top 5 ETFs holding ANGN
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ANGN. The ETFs are listed according to market value of ANGN within the ETF
---
Biofrontera
―
Satsuma Pharmaceuticals
―
Lowell Farms
―
Zynerba Pharmaceuticals
―
Real Brands
―
---